SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-003271
Filing Date
2020-01-13
Accepted
2020-01-13 09:20:34
Documents
8
Period of Report
2020-01-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1928324-4_8k.htm 8-K 21159
2 EXHIBIT 1.1 tm1928324d4_ex1-1.htm EX-1.1 245018
3 EXHIBIT 5.1 tm1928324d4_ex5-1.htm EX-5.1 6102
4 EXHIBIT 99.1 tm1928324d4_ex99-1.htm EX-99.1 8665
5 EXHIBIT 99.2 tm1928324d4_ex99-2.htm EX-99.2 8721
6 GRAPHIC tm1928324d4_ex99-1img01.jpg GRAPHIC 14029
7 GRAPHIC tm1928324d4_ex99-1img02.jpg GRAPHIC 13016
8 GRAPHIC tm1928324d4_ex99-2img01.jpg GRAPHIC 4031
  Complete submission text file 0001104659-20-003271.txt   334062
Mailing Address 909 DAVIS STREET SUITE 600 EVANSTON IL 60201
Business Address 1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201 847-871-0377
Aptinyx Inc. (Filer) CIK: 0001674365 (see all company filings)

IRS No.: 474626057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38535 | Film No.: 20523013
SIC: 2834 Pharmaceutical Preparations